(News) (not included in the study count)
Sermo reports: COVID-19 treatment trends over 6 weeks and 33,700 interviews: Usage, efficacy and safety perceptions of most-used therapies
HC Q used by 55% of physicians worldwide for COVID. Survey of 6,150 physicians.
Currently no formal study is available so this is not included in the study count.
Please send us corrections, updates, or comments.